Inhibition of Colon Cancer Recurrence via Exogenous TRAIL Delivery Using Gel-like Coacervate Microdroplets
Colon cancer (CC) belongs to the three major malignancies with a high recurrence rate. Therefore, a novel drug delivery system that can prevent CC recurrence while minimizing side effects is needed. Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) has recently been spotlighted as a pr...
Hlavní autoři: | , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2022-07-01
|
Edice: | Gels |
Témata: | |
On-line přístup: | https://www.mdpi.com/2310-2861/8/7/427 |